A biological nanopore detection method based on 3D DNA walker sensing and its application in MUC1 detection

By introducing 3D DNA walker sensing technology into biological nanopore detection, using DNAzyme to cleave and release DNA fragments, the sensitivity and specificity problems in MUC1 detection are solved, and high sensitivity and low cost detection is achieved, with extensive medical treatment. Application prospects.

CN114994310BActive Publication Date: 2024-11-05CHONGQING INST OF GREEN & INTELLIGENT TECH CHINESE ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210587001.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-05-26
Publication Date
2024-11-05
Estimated Expiration
2042-05-26

AI Technical Summary

Technical Problem

The existing biological nanopore detection methods have limited sensitivity and specificity for small molecular substances, especially in the detection of breast cancer marker MUC1, which has problems such as low sensitivity, low selectivity and high detection cost.

Method used

Using a bio-nanopore detection method based on 3D DNA walker sensing, the Zn2+-DNAzyme hybridized with MUC1 aptamer and fixed on Fe3O4 particles, DNAzyme was used to cleave the substrate strand to release DNA fragments, and bind to α-HL bio-nanopore detection signal. Amplify and improve detection sensitivity and specificity.

Benefits of technology

It realizes high sensitivity detection of MUC1, with the minimum detection amount up to 0.01nM, which reduces detection costs and improves signal-to-noise ratio, and has a wide range of medical diagnostic applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114994310B_ABST
    Figure CN114994310B_ABST
Patent Text Reader

Abstract

The present invention provides a biological nanopore detection method based on 3D DNA walker sensing and its application in MUC1 detection. The detection method comprises: 2+ The DNAzyme walking chain and the aptamer to be tested are hybridized, and then they are fixed on the Fe3O4 particles together with the biotin-modified hairpin substrate chain. When the aptamer to be tested specifically interacts with the aptamer to be tested, Zn is released. 2+ ‑DNAzyme, DNAzyme in Zn 2+ In the presence of a molecule, the hairpin substrate chain is cut to release the substrate chain DNA fragment; after the Fe3O4 particles are separated by a magnet, the released DNA fragment is detected by the α‑HL biological nanopore to obtain the concentration of the analyte. The biological nanopore detection method based on 3D DNA walker sensing provided by the present invention utilizes the signal amplification characteristics of the 3D DNA Walker nanoprobe and combines it with biological nanopore detection to greatly improve the sensitivity and signal-to-noise ratio of nanopore detection, and the minimum detection amount of MUC1 can reach 0.01nM.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the fields of molecular biology and nucleic acid chemistry, and in particular to a biological nanopore detection method based on 3D DNA walker sensing and its application in MUC1 detection. Background Art

[0002] Bionanopore single-molecule detection is an emerging detection technology that integrates multiple disciplines, including nanotechnology, biology, chemistry, and electronic information. α-Hemolysin (α-HL), a water-soluble protein monomer with a molecular weight of 33.2 kDa secreted by Staphylococcus aureus, assembles into a mushroom-shaped heptamer protein nanopore with a molecular weight of 232.4 kDa on a phospholipid bilayer. The total pore length is approximately 10 nm. This nanopore is structurally stable and can be fully loaded into the bilayer without leakage, making it an ideal nanopore detection device. The α-HL nanopore is geometrically divided into three major regions: cap, cis, and stem. Protein modifications at different locations, based on their molecular structure or atomic map, allow the design and fabrication of protein nanopores with various properties. This allows the study of steric and charge effects on the interaction between the channel and different analytes, enabling real-time detection of diverse analytes at the single-molecule level. Analytes can include inorganic ions, organic molecules, single-stranded DNA / RNA, and proteins.

[0003] However, the sensitivity and specificity of detection of some special small molecules are limited. How to amplify the signal to improve the sensitivity and specificity of detection has become a difficult problem that technicians in this field are working hard to overcome.

[0004] Breast cancer is the second leading cause of cancer death among women worldwide, with an estimated 626,279 deaths annually, second only to lung cancer. Early diagnosis is crucial for breast cancer treatment and a key factor in improving survival rates. Epithelial mucin-1 (MUC1) is a membrane glycoprotein overexpressed in 90% of breast cancers and serves as a useful marker for breast cancer. Currently reported methods for MUC1 detection primarily include enzyme-linked immunosorbent assay (ELISA), surface-enhanced Raman spectroscopy (SERS), fluorescence analysis, and electrochemical analysis. However, existing methods still suffer from low sensitivity, low selectivity, and high detection costs. Therefore, the development of MUC1 detection methods with high sensitivity, good selectivity, mild reaction conditions, and cost-effectiveness is urgently needed. Summary of the Invention

[0005] In view of this, in order to overcome the shortcomings of the existing technology, the present invention provides a biological nanopore detection method based on 3D DNA walker sensing and its application in MUC1 detection. This method utilizes the signal amplification characteristics of 3D DNA Walker nanoprobes and combines it with biological nanopore detection to significantly improve the sensitivity and signal-to-noise ratio of nanopore detection.

[0006] The present invention provides a biological nanopore detection method based on 3D DNA walker sensing, the method comprising:

[0007] 1) Zn with terminal biotin 2+ -DNAzyme walking chain and aptamer to be tested are hybridized, and then they and biotin-modified hairpin substrate chain are fixed on Fe3O4 particles respectively;

[0008] 2) The analyte specifically interacts with the aptamer to release Zn 2+ -DNAzyme, DNAzyme in Zn 2+ In the presence of , the hairpin substrate chain is cut to release the substrate chain DNA fragment;

[0009] 3) Separation of Fe3O4 particles by magnet;

[0010] 4) The released DNA fragments pass through the α-HL biological nanopore to detect the DNA fragment passing through the pore signal;

[0011] 5) Obtain the concentration of the analyte.

[0012] The present invention provides an application of a biological nanopore detection method based on 3D DNA walker sensing in MUC1 detection, the application comprising the steps of:

[0013] A. Zn with terminal biotin 2+ -DNAzyme walking chain and MUC1 aptamer hybridization, and then it and biotin-modified hairpin substrate chain were fixed on Fe3O4 particles to obtain 3D DNA walker nanoprobe;

[0014] B. The MUC1 to be tested specifically interacts with the MUC1 aptamer in the 3D DNA walker nanoprobe to release Zn 2+ -DNAzyme, DNAzyme in Zn 2+ In the presence of , the hairpin substrate chain is cut to release the substrate chain DNA fragment;

[0015] C. Separation of Fe3O4 particles by magnet;

[0016] D. The released DNA fragments pass through the α-HL biological nanopore to detect the DNA fragment passing through the pore signal;

[0017] E. Obtain MUC1 concentration.

[0018] Furthermore, the MUC1 aptamer is shown in SEQ No. 1; the Zn 2+ The DNAzyme walking chain is shown in SEQ No. 2; the biotin-modified hairpin substrate chain is shown in SEQ No. 3.

[0019] SEQ No.1:

[0020] GCAGTTGATCCTTTGGATACCCTGG;

[0021] SEQ No.2:

[0022] Biotin-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTCCAGGGTATCCAAAGGATCTTCTCCGAGCCGGTCGAAATAGT;

[0023] SEQ No.3:

[0024] Biotin-TTTTTTTTTTGACGACGCGTCATCAAAGCTCATACTATrAGAAGAGACTGCCCTTATTACGCGTCGTC.

[0025] Furthermore, the preparation of the 3D DNA walker nanoprobe in step A comprises the following steps:

[0026] A.1 To obtain a stable hairpin structure, heat the hairpin substrate at 95°C for 10 min and then gradually cool it to room temperature;

[0027] A.2 Mix the DNAzyme walking strand and the aptamer strand and incubate them in Tris-HCl buffer at 37°C for 2 h to obtain a double-stranded structure with complementary aptamer and walking strand;

[0028] A.3 Add the substrate strand and pre-prepared aptamer walking strand to Fe3O4 and shake for 16 hours. Finally, remove free DNA with a magnet and resuspend in Tris-HCl.

[0029] Furthermore, the molar ratio of the DNAzyme walking chain to the aptamer chain is 1:1.2.

[0030] Furthermore, in step B, the MUC1 to be detected specifically interacts with the MUC1 aptamer in the 3D DNA walker nanoprobe to release Zn 2+-DNAzyme, DNAzyme in Zn 2+ In the presence of Fe3O4, the hairpin substrate chain is cut and hydrolyzed at the scissor-like rA; the hairpin substrate chain is divided into two fragments, and the DNA away from the Fe3O4 end is released.

[0031] Furthermore, the DNA fragment to be detected is shown as SEQ No.4.

[0032] SEQ No. 4: GAAGAGACTGCCCTTATTACGCGTCGTC.

[0033] Furthermore, the preparation of the α-HL biological nanopore comprises the steps of:

[0034] A diphytylphosphatidylcholine (DPhPC) bilayer membrane is formed within a peek tube; the phospholipid bilayer membrane is divided into two chambers, cis and trans; a Tris-HCl conductive buffer containing KCl is added to both sides of the chamber; the ionic current passing through the nanopore is measured using an Ag / AgCl electrode; and α-hemolysin protein is injected near the cis chamber, and insertion of the α-HL biological nanopore is confirmed by a clear jump in the current value.

[0035] Furthermore, detecting the DNA fragment passing through the pore signal by the α-HL biological nanopore comprises the following steps:

[0036] The DNA solution to be tested was added to the cis chamber; the channel current was measured by a patch clamp amplifier Axon 200B equipped with a Digidata 1440A A / D converter; and the signal was filtered at 5 kZ.

[0037] Furthermore, the numerical analysis and graphical presentation of all current measurement data were performed using Clampfit software and origin9.0 software. The average residence time and average interval time values ​​were obtained from the histograms formed by the analysis, and the interval histograms were fitted to a single exponential function. The standard deviation I0 of the open pore current was obtained by fitting a Gaussian function to the single-channel current baseline histogram. The average signal amplitude and current blocking rate ΔI / I0 were obtained from the signal amplitude.

[0038] The present invention firstly converts Zn with terminal biotin into 2+ -DNAzyme walking chain and MUC1 aptamer hybridization, and then it and the biotin-modified hairpin substrate chain were fixed on Fe3O4 particles, and then MUC1 was added to the system. Due to the specific interaction between MUC1 and aptamer, Zn 2+ -DNAzyme, then in Zn 2+In the presence of DNAzyme, the hairpin substrate strand is cleaved, releasing DNA fragments. The Fe3O4 particles are separated by a magnet, and the free DNA fragments are detected using nanopore technology.

[0039] The present invention provides a method for detecting MUC1 using a biological nanopore based on 3D DNA walker sensing. A nanoprobe is constructed by combining Fe3O4 with a MUC1 aptamer hybridized with a DNAzyme walking chain and a hairpin substrate chain to achieve a signal amplification strategy. In the presence of the MUC1 target, MUC1 binds to the aptamer and releases the DNAzyme walking chain. 2+ In the presence of a DNAzyme, the walking strand cleaves the hairpin substrate strand, releasing free DNA. The released DNA fragments are then detected by the α-HL nanopore, generating a permeation signal. This establishes a highly sensitive and specific sensing system.

[0040] Compared with the prior art, the present invention has the following beneficial effects:

[0041] 1. The present invention provides a biological nanopore detection method based on 3D DNA walker sensing. By leveraging the signal amplification properties of 3D DNA Walker nanoprobes and combining this with biological nanopore detection, the method can significantly improve the sensitivity and signal-to-noise ratio of nanopore detection. The minimum detectable amount can reach 0.01 nM.

[0042] 2. The novel single-molecule nanopore MUC1 detection method disclosed in this invention, based on a 3D DNA Walker nanoprobe, features simple sample preparation, convenient operation, and low cost, possessing promising application prospects. In particular, the detection, evaluation, and processing of MUC1 in human blood are currently in urgent need of developing convenient, low-cost, and highly sensitive detection methods and approaches to monitor human health. This method provides an assessment approach for early medical diagnosis and holds broad application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

[0043] To more clearly illustrate the technical solutions for implementing the present invention, the following briefly introduces the drawings required for use in the embodiments or descriptions of the prior art. Obviously, the drawings described below are some embodiments of the present invention, and those skilled in the art can derive other drawings based on these drawings without inventive effort.

[0044] Figure 1 Schematic diagram of the principle of detecting MUC1 using biological nanopore based on 3D DNA Walker sensing in the present invention;

[0045] Figure 2Single-channel current traces at different MUC1 concentrations, ranging from 0.01 to 100 nM (from top to bottom);

[0046] Figure 3 Analysis of the linear relationship between MUC1 protein concentration and event frequency (data were obtained at 1 M KCl + 130 mV applied voltage);

[0047] Figure 4 Current traces of serum samples (left) and serum samples containing MUC1 (right). DETAILED DESCRIPTION

[0048] In order to make the purpose, technical solutions and advantages of the embodiments of the present invention more clear, the specific implementation of the present invention is clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all the embodiments. Based on the embodiments of the present invention, all other implementation methods obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0049] Example 1: Construction of nanopore biosensor

[0050] 1) Formation of phospholipid bilayer membrane:

[0051] Prepare solution A: Mix 25 mg of phospholipid with 2.5 mL of pentane;

[0052] Prepare 50 mL of the ionic buffer required for the experiment: 1 M KCl, 10 mM Tris (pH = 7.5), and filter through a 0.45 m filter.

[0053] Use a pipette tip to scoop up 1 μL of solution A and drop it onto the peek tube near the micrometer aperture in the detection cell. After solution A evaporates, use a pipette to add a small amount of ion buffer to each of the cis and trans compartments. Insert a pair of Ag / AgCl electrodes connected to the patch clamp system into the ion buffer in each of the cis and trans compartments.

[0054] Observe whether a phospholipid bilayer membrane has formed. If so, proceed to the next experiment. If not, use a pipette to slowly and repeatedly pipette the ion buffer through the well several times until a phospholipid bilayer membrane is formed. During the formation of the phospholipid bilayer membrane, the membrane capacitance is measured in a patch clamp system to determine its formation quality, and the membrane voltage is used to examine the mechanical strength of the phospholipid bilayer.

[0055] 2) Formation of α-HL bionanopore biosensor

[0056] In a peek tube, a phospholipid bilayer is formed at the opening of an orifice with a diameter of approximately 100 μm, divided into two chambers: the cis and trans chambers. Approximately 100 μL of conductive buffer (1 M KCl and 10 mM Tris-HCl) is added to each chamber. The cis and trans nanopores are connected by a pair of Ag / AgCl electrodes. α-Hemolysin protein (0.01-0.1 ng / mL) is added to the cis chamber to self-assemble a transmembrane heptameric protein channel. The current is amplified and measured by a patch clamp amplifier (Axon 200B) connected to a Digidata 1440A A / D converter, and the signal is filtered at 5 kHz.

[0057] Example 2: Performance test of α-HL bionanopore biosensor

[0058] The performance of the nanopore biosensor will be optimized and tested based on analytical parameters such as electrolyte, operating voltage, Gaussian distribution, linear range, detection limit, blockage amplitude, and blockage time.

[0059] Example 3: Preparation of 3D DNA Walker Nanoprobe

[0060] To obtain a stable hairpin structure, 10 μM hairpin substrate was heated at 95°C for 10 min and then gradually cooled to room temperature. 2+ -DNAzyme walking chain (10 μM) and 48 μL MUC1 aptamer (10 μM) were incubated in Tris-HCl buffer at 37°C for 2 h to obtain a double-stranded structure with complementary aptamer and walking chain; Zn 2+ -DNAzyme walking chain and aptamer chain were mixed at a molar ratio of 1:1.2, so that Zn 2+ The DNAzyme chain was completely blocked by the aptamer chain. Then, 100 μL of hairpin substrate (20 μM) and 24 μL of pre-prepared aptamer walking chain (4.5 μM) were added to 1 mg / mL streptavidin-modified Fe₃O₄ and shaken for 16 hours. Finally, the Fe₃O₄ was adsorbed with a magnet to remove free DNA, and the solution was resuspended in Tris-HCl to obtain the 3D DNA Walker nanoprobe.

[0061] Example 4: Cleavage of hairpin substrate strand

[0062] The prepared 3D DNA walker nanoprobe (1 nM) was incubated with the tested concentration of MUC1 in Tris-HCl buffer at 37°C for 1 h. MUC1 specifically interacted with the MUC1 aptamer in the 3D DNA walker nanoprobe to release Zn 2+ -DNAzyme, in the absence of Zn 2+In the case of Zn, DNAzyme is not activated, so the hairpin substrate chain cannot be cut. 2+ In the presence of 20 μM, DNAzyme catalyzes the hydrolytic cleavage of the hairpin substrate strand at the cleaved rA site. The hairpin substrate strand is separated into two fragments. One fragment, linked to Fe₃O₄, is removed by magnetic separation, and the DNA of the other fragment is detected using the α-HL bionanopore.

[0063] Example 5: Nanopore Indirect Detection of MUC1

[0064] The aptamer in the 3D DNA Walker nanoprobe blocked the DNAzyme walking chain in the absence of MUC1 without cutting the biotin-modified hairpin substrate, so the DNA fragment could not be released. No blocking current was observed in the laboratory under an applied voltage of 130mV. In the presence of target MUC1, when the aptamer binds to MUC1, the DNAzyme walking chain is unwound and cleaves the biotin-modified hairpin substrate. When tested with an α-HL biological nanopore, the released DNA fragments produced a blocking signal. In order to evaluate the sensitivity of the nanopore sensor, the inventors examined the sensitivity of MUC1 at different concentrations under optimal conditions, testing the changes in the frequency of events caused by the protein, such as Figure 2 、 3 shown.

[0065] Example 6: Nanopore electrical recording and data analysis

[0066] A DPhPC bilayer membrane with a diameter of 100 μm was formed in a peek tube. The lipid bilayer was divided into two compartments: the cis and trans chambers. Approximately 100 μL of a conductive buffer consisting of 1 M KCl and 10 mM Tris-HCl was added to each chamber. The ionic current through the nanopore was measured using an Ag / AgCl electrode. α-Hemolysin protein (0.01–0.1 ng / mL) was injected near the cis chamber, and pore insertion was confirmed by a clear jump in the current. Once a stable single pore insertion was detected, the DNA solution to be tested was added to the cis chamber. The channel current was measured using an Axon 200B patch clamp amplifier equipped with a Digidata 1440A A / D converter (Molecular Devices, Sunnyvale, USA). The signal was filtered at 5 kHz. Numerical analysis and graphical presentation of all recorded data were performed using Clampfit software (Molecular Devices, Sunnyvale, USA) and Origin 9.0 software. The mean dwell time and mean interval time values ​​were obtained from the histogram, and the interval histogram was fitted to a single exponential function. The standard deviation of the open pore current, I0, was obtained by fitting a Gaussian function to the single-channel current baseline histogram. The mean signal amplitude and current blockade ratio (ΔI / I0) were obtained from the signal amplitude.

[0067] Example 7: Verification of the specificity of MUC1 and aptamer

[0068] In addition to sensitivity, the specificity of MUC1 and the aptamer was also verified. 1 nM concentrations of BSA, CEA, PSA, and thrombin were added to a 0.1 nM concentration of MUC1 for comparison. The results showed that the specificity of MUC1 detection was not affected by other proteins.

[0069] Example 8: Actual sample detection

[0070] To further evaluate the applicability of the present method in analyzing real biological samples, the inventors used this method to test human serum as a target sample. While the current signal generated by the original serum sample had low-level noise-like peaks, the addition of MUC1 (0.1 nM) produced a large number of specific characteristic peaks that could be easily distinguished from each other. (e.g., Figure 4 shown)

[0071] In summary, the novel 3D DNA Walker nanoprobe provided by the present invention achieves the goal of indirect single-molecule nanopore detection of MUC1 by leveraging the specific interaction between MUC1 and an aptamer. This method, leveraging the signal amplification properties of the 3D DNA Walker nanoprobe, significantly improves the sensitivity and signal-to-noise ratio of nanopore detection compared to simple MUC1 detection, achieving a detection limit of 0.01 nM, surpassing previously published results for MUC1 detection using other methods.

[0072] It should be noted that the above-described specific embodiments can enable those skilled in the art to more fully understand the present invention, but do not limit the present invention in any way. Therefore, although this specification has described the present invention in detail with reference to the drawings and embodiments, those skilled in the art should understand that the present invention can still be modified or replaced with equivalents without departing from the purpose and scope of the technical solution of the present invention, and all such modifications or equivalent replacements should be included in the scope of the claims of the present invention.

[0073] Finally, it should be noted that the above preferred embodiments are only used to illustrate the technical solutions of the present invention and are not limiting. Although the present invention has been described in detail through the above preferred embodiments, those skilled in the art should understand that various changes can be made in form and details without departing from the scope defined by the claims of the present invention. SEQUENCE LISTING <110> Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences <120> A 3D DNA-based Walker-sensing biological nanopore detection method and its application in MUC1 detection <130> Preparation method and application of electrochemiluminescent aptamer sensor for detecting tumor marker MUC1 <160> 4 <170> PatentIn version 3.5 <210> 1 <211> 25 <212> DNA <213> Artificial sequence <400> 1 gcagttgatc ctttggatac cctgg 25 <210> 2 <211> 84 <212> DNA <213> Artificial sequence <400> 2 tttttttttt tttttttttt tttttttttt tttttttttt ttccagggta tccaaaggat 60 cttctccgag ccggtcgaaa tagt 84 <210> 3 <211> 70 <212> DNA <213> Artificial Sequence <400> 3 tttttttttt ttgacgacgc gtcatcaaag ctcatactat ragaagagac tgcccttatt 60 acgcgtcgtc 70 <210> 4 <211> 28 <212> DNA <213> Artificial Sequence <400> 4 gaagagactg cccttattac gcgtcgtc 28

Claims

1. A biological nanopore detection method based on 3D DNA walker sensing, characterized in that: The method comprises: 1) Zn with terminal biotin 2+ -DNAzyme walking strand and aptamer to be detected are hybridized, and then they are fixed on Fe3O4 particles together with biotin-modified hairpin substrate strands; 2) The analyte specifically interacts with the aptamer to release Zn 2+ -DNAzyme, DNAzyme in Zn 2+ In the presence of , the hairpin substrate strand is cut to release the substrate strand DNA fragment; 3) Separation of Fe3O4 particles by magnet; 4) The released DNA fragments pass through the α-HL biological nanopore to detect the DNA fragment passing through the pore signal; 5) Obtain the concentration of the analyte.

2. The application of the biological nanopore detection method based on 3D DNA walker sensing in MUC1 detection according to claim 1, characterized in that: The application comprises the steps of: A. Zn with terminal biotin 2+ -DNAzyme walking chain and MUC1 aptamer were hybridized, and then they were fixed on Fe3O4 particles together with biotin-modified hairpin substrate chain to obtain 3D DNA walker nanoprobe; B. The MUC1 to be tested specifically interacts with the MUC1 aptamer in the 3D DNA walker nanoprobe to release Zn 2+ -DNAzyme, DNAzyme in Zn 2+ In the presence of , the hairpin substrate strand is cut to release the substrate strand DNA fragment; C. Separation of Fe3O4 particles by magnet; D. The released DNA fragments pass through the α-HL biological nanopore to detect the DNA fragment passing through the pore signal; E. Obtain MUC1 concentration.

3. Application of the biological nanopore detection method based on 3D DNA walker sensing in MUC1 detection according to claim 2, characterized in that: The MUC1 aptamer is shown in SEQ No. 1; the Zn 2+ -The DNAzyme walking chain is shown in SEQ No. 2; the biotin-modified hairpin substrate chain is shown in SEQ No.

3.

4. The use of the biological nanopore detection method based on 3D DNA walker sensing in MUC1 detection according to claim 2, characterized in that: The preparation of the 3D DNA walker nanoprobe in step A comprises the following steps: A.1 To obtain a stable hairpin structure, the hairpin substrate was heated at 95°C for 10 min and then gradually cooled to room temperature; A.2 Mix the DNAzyme walking chain and the aptamer chain, incubate them in Tris-HCl buffer at 37 °C for 2 h, and obtain a double-stranded structure complementary to the aptamer and the walking chain; A.3 Add the substrate chain and the pre-prepared aptamer walking chain into Fe3O4 and oscillate for 16 h; finally, remove the free DNA with a magnet and resuspend in Tris-HCl.

5. Application of the biological nanopore detection method based on 3D DNA walker sensing in MUC1 detection according to claim 4, characterized in that: The molar ratio of the DNAzyme walking chain to the aptamer chain is 1:1.

2.

6. Application of the biological nanopore detection method based on 3D DNA walker sensing in MUC1 detection according to claim 2, characterized in that: Step B: The MUC1 to be detected specifically interacts with the MUC1 aptamer in the 3D DNA walker nanoprobe to release Zn 2+ -DNAzyme, DNAzyme in Zn 2+ In the presence of Fe3O4, the hairpin substrate chain is cut and hydrolyzed at the scissor-like rA; the hairpin substrate chain is divided into two fragments, and the DNA away from the Fe3O4 end is released.

7. Application of the biological nanopore detection method based on 3D DNA walker sensing in MUC1 detection according to claim 2, characterized in that: The released DNA fragment is shown in SEQ No.

4.

8. Application of the biological nanopore detection method based on 3D DNA walker sensing in MUC1 detection according to claim 2, characterized in that: The preparation of the α-HL biological nanopore comprises the following steps: A diphytylphosphatidylcholine (DPhPC) bilayer membrane is formed in a peek tube; the phospholipid bilayer membrane is divided into two chambers, cis and trans; a Tris-HCl conductive buffer containing KCl is added to both sides of the chamber; an Ag / AgCl electrode is used to measure the ion current passing through the nanopore; an α-hemolysin protein is injected near the cis chamber, and the insertion of the α-HL biological nanopore is determined by a clear jump in the current value.

9. Application of the biological nanopore detection method based on 3D DNA walker sensing in MUC1 detection according to claim 8, characterized in that: Detecting the DNA fragment passing through the pore signal by the α-HL biological nanopore comprises the following steps: The DNA solution to be tested was added to the cis chamber; the channel current was measured by a patch clamp amplifier Axon 200B equipped with a Digidata 1440A A / D converter; and the signal was filtered at 5 kz.

10. Application of the biological nanopore detection method based on 3D DNA walker sensing in MUC1 detection according to claim 9, characterized in that: The numerical analysis and graphical representation of all current measurement data were performed using Clampfit software and origin 9.0 software. The average residence time and average interval time values ​​were obtained from the histograms formed by the analysis, and the interval histograms were fitted to a single exponential function. The standard deviation I0 of the open current was obtained by fitting a Gaussian function to the single-channel current baseline histogram. The average signal amplitude and current blocking rate ΔI / I0 were obtained from the signal amplitude.